Home |
Climate Change Project |
Table of Contents |
Courses | Search |
![]()
From the U.S. House of Representatives Downloadable U.S. Code
[uscode.house.gov]
[Laws in effect as of January 5, 1999]
[CITE: 42USC300aa-1]
TITLE 42 - THE PUBLIC HEALTH AND WELFARE
CHAPTER 6A - PUBLIC HEALTH SERVICE
SUBCHAPTER XIX - VACCINES
Part 1 - National Vaccine Program
-HEAD-
Sec. 300aa-1. Establishment
-STATUTE-
The Secretary shall establish in the Department of Health and
Human Services a National Vaccine Program to achieve optimal
prevention of human infectious diseases through immunization and to
achieve optimal prevention against adverse reactions to vaccines.
The Program shall be administered by a Director selected by the
Secretary.
-SOURCE-
(July 1, 1944, ch. 373, title XXI, Sec. 2101, as added Pub. L.
99-660, title III, Sec. 311(a), Nov. 14, 1986, 100 Stat. 3756.)
-MISC1-
PRIOR PROVISIONS
A prior section 300aa-1, act July 1, 1944, Sec. 2102, was
successively renumbered by subsequent acts and transferred, see
section 238a of this title.
A prior section 2101 of act July 1, 1944, was successively
renumbered by subsequent acts and transferred, see section 238 of
this title.
EFFECTIVE DATE
Section 323 of title III of Pub. L. 99-660, as amended by Pub. L.
100-203, title IV, Sec. 4302(a), Dec. 22, 1987, 101 Stat. 1330-221;
Pub. L. 102-168, title II, Sec. 201(a), Nov. 26, 1991, 105 Stat.
1102, provided that: ''Subtitle 1 of title XXI of the Public Health
Service Act (part 1 of this subchapter (42 U.S.C. 300aa-1 to
300aa-6)) shall take effect on the date of the enactment of this
Act (Nov. 14, 1986) and parts A and B of subtitle 2 of such title
(subparts A and B of part 2 of this subchapter (42 U.S.C. 300aa-10
to 300aa-23)) shall take effect on October 1, 1988 and parts C and
D of such title (subparts C and D of part 2 of this subchapter (42
U.S.C. 300aa-25 to 300aa-33)) and this title (probably means
provisions of title III of Pub. L. 99-660 other than those that
enacted this subchapter and redesignated former sections 300aa to
300aa-15 of this title as sections 300cc to 300cc-15 of this title;
these other provisions amended sections 218, 242c, 262, 286, and
289f of this title and enacted provisions set out as notes under
sections 201, 300aa-1, and 300aa-4 of this title) shall take effect
on the date of the enactment of the Vaccine Compensation Amendments
of 1987 (Dec. 22, 1987).''
SEVERABILITY
Section 322 of title III of Pub. L. 99-660, as amended by Pub. L.
101-239, title VI, Sec. 6602, Dec. 19, 1989, 103 Stat. 2293; Pub.
L. 101-502, Sec. 5(g)(1), Nov. 3, 1990, 104 Stat. 1288, provided
that:
''(a) In General. - Except as provided in subsection (b), if any
provision (of) part A or B of subtitle 2 of title XXI of the Public
Health Service Act (subparts A and B of part 2 of this subchapter),
as added by section 311(a), or the application of such a provision
to any person or circumstance is held invalid by reason of a
violation of the Constitution, both such parts shall be considered
invalid.
''(b) Special Rule. - If any amendment made by section 6601 of
the Omnibus Budget Reconciliation Act of 1989 (Pub. L. 101-239,
amending sections 300aa-10 to 300aa-17, 300aa-21, 300aa-23,
300aa-26, and 300aa-27 of this title) to title XXI of the Public
Health Service Act (this subchapter) or the application of such a
provision to any person or circumstance is held invalid by reason
of the Constitution, subsection (a) shall not apply and such title
XXI of the Public Health Service Act without such amendment shall
continue in effect.''
(Amendment by section 5(g)(1) of Pub. L. 101-502 to section
322(a) of Pub. L. 99-660, set out above, effective Nov. 14, 1986,
see section 5(h) of Pub. L. 101-502, set out as an Effective Date
of 1990 Amendment note under section 300aa-11 of this title.)
EVALUATION OF PROGRAM; STUDY AND REPORT TO CONGRESS
Pub. L. 101-239, title VI, Sec. 6601(t), Dec. 19, 1989, 103 Stat.
2293, as amended by Pub. L. 102-168, title II, Sec. 201(b), Nov.
26, 1991, 105 Stat. 1103, directed the Secretary of Health and
Human Services to evaluate the National Vaccine Injury Compensation
Program under this subchapter and report results of such study to
Committee on Energy and Commerce of House of Representatives and
Committee on Labor and Human Resources of Senate not later than
Jan. 1, 1993.
RELATED STUDIES
Section 312 of title III of Pub. L. 99-660 directed Secretary of
Health and Human Services, not later than 3 years after the
effective date of this title (see Effective Date note above), to
conduct, through studies by the Institute of Medicine of the
National Academy of Sciences or other appropriate nonprofit private
groups or associations, a review of pertussis vaccines and related
illnesses and conditions and MMR vaccines, vaccines containing
material intended to prevent or confer immunity against measles,
mumps, and rubella disease, and related illnesses and conditions,
make specific findings and report these findings in the Federal
Register not later than 3 years after the effective date of this
title, and at the same time these findings are published in the
Federal Register, propose regulations as a result of such findings,
and not later than 42 months after the effective date of this
title, promulgate such proposed regulations with such modifications
as may be necessary after opportunity for public hearing.
STUDY OF OTHER VACCINE RISKS
Section 313 of title III of Pub. L. 99-660 provided that:
''(a) Study. -
''(1) Not later than 3 years after the effective date of this
title (see Effective Date note above), the Secretary shall, after
consultation with the Advisory Commission on Childhood Vaccines
established under section 2119 of the Public Health Service Act
(section 300aa-19 of this title) -
''(A) arrange for a broad study of the risks (other than the
risks considered under section 102 (21 U.S.C. 382)) to children
associated with each vaccine set forth in the Vaccine Injury
Table under section 2114 of such Act (section 300aa-14 of this
title), and
''(B) establish guidelines, after notice and opportunity for
public hearing and consideration of all relevant medical and
scientific information, respecting the administration of such
vaccines which shall include -
''(i) the circumstances under which any such vaccine should
not be administered,
''(ii) the circumstances under which administration of any
such vaccine should be delayed beyond its usual time of
administration, and
''(iii) the groups, categories, or characteristics of
potential recipients of such vaccine who may be at
significantly higher risk of major adverse reactions to such
vaccine than the general population of potential recipients.
''(2)(A) The Secretary shall request the Institute of Medicine
of the National Academy of Sciences to conduct the study required
by paragraph (1) under an arrangement by which the actual
expenses incurred by such Academy in conducting such study will
be paid by the Secretary.
''(B) If the Institute of Medicine is unwilling to conduct such
study under such an arrangement, the Secretary shall enter into a
similar arrangement with other appropriate nonprofit private
groups or associations under which such groups or associations
will conduct such study.
''(C) The Institute of Medicine or other group or association
conducting the study required by paragraph (1) shall conduct such
studies in consultation with the Advisory Commission on Childhood
Vaccines established under section 2119 of the Public Health
Service Act (section 300aa-19 of this title).
''(b) Revision of Guidelines. - The Secretary shall periodically,
but at least every 3 years after establishing guidelines under
subsection (a), review and revise such guidelines after notice and
opportunity for public hearing and consideration of all relevant
medical and scientific information, unless the Secretary finds that
on the basis of all relevant information no revision of such
guidelines is warranted and publishes such finding in the Federal
Register.
''(c) Factors Affecting Guidelines. - Guidelines under subsection
(a) shall take into account -
''(1) the risk to potential recipients of the vaccines with
respect to which the guidelines are established,
''(2) the medical and other characteristics of such potential
recipients, and
''(3) the risks to the public of not having such vaccines
administered.
''(d) Dissemination. - The Secretary shall widely disseminate the
guidelines established under subsection (a) to -
''(1) physicians and other health care providers,
''(2) professional health associations,
''(3) State and local governments and agencies, and
''(4) other relevant entities.''
REVIEW OF WARNINGS, USE INSTRUCTIONS, AND PRECAUTIONARY INFORMATION
Section 314 of title III of Pub. L. 99-660 directed Secretary of
Health and Human Services, not later than 1 year after the
effective date of this title (see Effective Date note above) and
after consultation with Advisory Commission on Childhood Vaccines
and with other appropriate entities, to review the warnings, use
instructions, and precautionary information presently issued by
manufacturers of vaccines set forth in the Vaccine Injury Table set
out in section 300aa-14 of this title and by rule determine whether
such warnings, instructions, and information adequately warn health
care providers of the nature and extent of dangers posed by such
vaccines, and, if any such warning, instruction, or information is
determined to be inadequate for such purpose in any respect,
require at the same time that the manufacturers revise and reissue
such warning, instruction, or information as expeditiously as
practical, but not later than 18 months after the effective date of
this title.
STUDY OF IMPACT ON SUPPLY OF VACCINES
Section 316 of title III of Pub. L. 99-660 provided that: ''On
June 30, 1987, and on June 30 of each second year thereafter, the
Secretary of Health and Human Services shall submit to the
Committee on Energy and Commerce (now Committee on Commerce) of the
House of Representatives and the Committee on Labor and Human
Resources of the Senate -
''(1) an assessment of the impact of the amendments made by
this title (enacting this subchapter, amending sections 218,
242c, 262, 286, and 289f of this title, redesignating former
sections 300aa to 300aa-15 of this title as sections 300cc to
300cc-15 of this title, and enacting provisions set out as notes
under this section and sections 201 and 300aa-1 of this title) on
the supply of vaccines listed in the Vaccine Injury Table under
section 2114 of the Public Health Service Act (section 300aa-14
of this title), and
''(2) an assessment of the ability of the administrators of
vaccines (including public clinics and private administrators) to
provide such vaccines to children.''
WAIVER OF PAPERWORK REDUCTION
Section 321 of title III of Pub. L. 99-660 provided that:
''Chapter 35 of title 44, United States Code, shall not apply to
information required for purposes of carrying out this title and
implementing the amendments made by this title (enacting this
subchapter, amending sections 218, 242c, 262, 286, and 289f of this
title, redesignating former sections 300aa to 300aa-15 of this
title as sections 300cc to 300cc-15 of this title, and enacting
provisions set out as notes under sections 201, 300aa-1, and
300aa-4 of this title).''
FDA/Website Management Staff
Web page created by smc 2000-NOV-14.
The Climate Change and Public Health Law Site
The Best on the WWW Since 1995!
Copyright as to non-public domain materials
See DR-KATE.COM for home hurricane and disaster preparation
See WWW.EPR-ART.COM for photography of southern Louisiana and Hurricane Katrina
Professor Edward P. Richards, III, JD, MPH - Webmaster
Provide Website Feedback - https://www.lsu.edu/feedback
Privacy Statement - https://www.lsu.edu/privacy
Accessibility Statement - https://www.lsu.edu/accessibility